Literature DB >> 11274629

Varicella vaccine--the first six years.

A M Arvin.   

Abstract

Mesh:

Substances:

Year:  2001        PMID: 11274629     DOI: 10.1056/NEJM200103293441310

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  A systematic approach for the identification of novel, serologically reactive recombinant Varicella-Zoster Virus (VZV) antigens.

Authors:  Maria G Vizoso Pinto; Klaus-Ingmar Pfrepper; Tobias Janke; Christina Noelting; Michaela Sander; Angelika Lueking; Juergen Haas; Hans Nitschko; Gundula Jaeger; Armin Baiker
Journal:  Virol J       Date:  2010-07-20       Impact factor: 4.099

2.  An outbreak of varicella among schoolchildren in Taipei.

Authors:  Chao-Chih Lai; Szu-Ching Chen; Donald Dah-Shyong Jiang
Journal:  BMC Public Health       Date:  2011-04-12       Impact factor: 3.295

3.  The differences in short- and long-term varicella-zoster virus (VZV) immunoglobulin G levels following varicella vaccination of healthcare workers measured by VZV fluorescent-antibody-to-membrane-antigen assay (FAMA), VZV time-resolved fluorescence immunoassay and a VZV purified glycoprotein enzyme immunoassay.

Authors:  P A C Maple; J Haedicke; M Quinlivan; S P Steinberg; A A Gershon; K E Brown; J Breuer
Journal:  Epidemiol Infect       Date:  2016-03-28       Impact factor: 2.451

4.  Viral vaccine meeting held in Barcelona, October 25-28, 2003.

Authors:  A C M Boon; S Plotkin; G F Rimmelzwaan; A D M E Osterhaus
Journal:  Vaccine       Date:  2004-03-29       Impact factor: 3.641

Review 5.  A review of licensed viral vaccines, some of their safety concerns, and the advances in the development of investigational viral vaccines.

Authors:  David B Huang; Jashin J Wu; Stephen K Tyring
Journal:  J Infect       Date:  2004-10       Impact factor: 6.072

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.